We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-20.47%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$9.64B
AUM Growth
-$2.48B
Cap. Flow
+$636M
Cap. Flow %
6.6%
Top 10 Hldgs %
42.18%
Holding
1,253
New
58
Increased
575
Reduced
265
Closed
42

Sector Composition

Rank Sector Weight
1 Real Estate 70.9%
2 Technology 5.34%
3 Financials 3.16%
4 Healthcare 3.13%
5 Industrials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZGNX
1076
DELISTED
Zogenix, Inc.
ZGNX
$6K ﹤0.01%
250
ESPR
1077
DELISTED
Esperion Therapeutics
ESPR
$5K ﹤0.01%
154
OPK icon
1078
Opko Health
OPK
$1.02B
$5K ﹤0.01%
3,729
SUPN icon
1079
Supernus Pharmaceuticals
SUPN
$2.7B
$5K ﹤0.01%
296
RVNC
1080
DELISTED
Revance Therapeutics, Inc.
RVNC
$5K ﹤0.01%
317
+37
+13% +$765
AXNX
1081
DELISTED
Axonics, Inc. Common Stock
AXNX
$5K ﹤0.01%
192
NGM
1082
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$5K ﹤0.01%
376
NSTG
1083
DELISTED
NanoString Technologies, Inc.
NSTG
$5K ﹤0.01%
202
ENDP
1084
DELISTED
Endo International plc
ENDP
$5K ﹤0.01%
1,280
AIMT
1085
DELISTED
Aimmune Therapeutics
AIMT
$5K ﹤0.01%
357
ADVM
1086
DELISTED
Adverum Biotechnologies
ADVM
$4K ﹤0.01%
44
+7
+19% +$816
AMPH icon
1087
Amphastar Pharmaceuticals
AMPH
$907M
$4K ﹤0.01%
265
CERS icon
1088
Cerus
CERS
$575M
$4K ﹤0.01%
871
CYTK icon
1089
Cytokinetics
CYTK
$10.6B
$4K ﹤0.01%
363
GMAB icon
1090
Genmab
GMAB
$17.5B
$4K ﹤0.01%
171
GOSS icon
1091
Gossamer Bio
GOSS
$101M
$4K ﹤0.01%
373
HCM icon
1092
HUTCHMED
HCM
$1.96B
$4K ﹤0.01%
235
INO icon
1093
Inovio Pharmaceuticals
INO
$85.6M
$4K ﹤0.01%
47
+5
+12% +$308
NTLA icon
1094
Intellia Therapeutics
NTLA
$1.51B
$4K ﹤0.01%
288
OMER icon
1095
Omeros
OMER
$845M
$4K ﹤0.01%
309
PAR icon
1096
CALL
PAR Technology
PAR
$716M
$4K ﹤0.01%
+96
New +$2.51K
RCKT icon
1097
Rocket Pharmaceuticals
RCKT
$343M
$4K ﹤0.01%
284
RYTM icon
1098
Rhythm Pharmaceuticals
RYTM
$7.31B
$4K ﹤0.01%
248
SGMO
1099
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4K ﹤0.01%
654
STOK icon
1100
Stoke Therapeutics
STOK
$1.84B
$4K ﹤0.01%
185

Similar funds

Daiwa Securities Group's Q1 2020 Portfolio in Review

As of Q1 2020, Daiwa Securities Group held 1,253 positions worth $9.64B, down 20% from $12.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Daiwa Securities Group deployed $636M of net new capital in Q1 2020, opening 58 new positions and adding to 575 existing holdings. Its largest new stake was Global X Conscious Companies ETF: 6,650,000 shares worth $122M.

By sector, the portfolio is most concentrated in Real Estate at 71% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Realty Income, an estimated $178M trimmed.

  • Daiwa Securities Group's largest Q1 2020 buy was Global X Conscious Companies ETF: 6,650,000 shares worth $122M.
  • Daiwa Securities Group added most to Public Storage in Q1 2020, an estimated $250M increase.
  • Daiwa Securities Group's biggest Q1 2020 reduction was Realty Income, cutting an estimated $178M.
  • Daiwa Securities Group fully exited RTX Corp in Q1 2020, selling an estimated $10.1M.
  • Daiwa Securities Group's ten largest holdings make up 42% of its $9.64B portfolio in Q1 2020.
  • Daiwa Securities Group opened 58 new positions and closed 42 in Q1 2020.
  • Daiwa Securities Group's portfolio value fell 20% quarter-over-quarter to $9.64B.

Based on Daiwa Securities Group's 13F filing for Q1 2020, filed 14 May 2020.